Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 9/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.56 |
| ▸ | NPC1 | O15118 | 4/20 | 0.56 |
| ▸ | RAB9A | P51151 | 4/20 | 0.56 |
| ▸ | LMNA | P02545 | 3/20 | 0.56 |
| ▸ | PTPN7 | P35236 | 3/20 | 0.43 |
| ▸ | PTPN12 | Q05209 | 3/20 | 0.43 |
| ▸ | PTPN22 | Q9Y2R2 | 3/20 | 0.43 |
| ▸ | THRB | P10828 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 4/20 | 0.41 |
| ▸ | HTT | P42858 | 3/20 | 0.41 |
| ▸ | TP53 | P04637 | 3/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | ORAI1 | Q96D31 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | PKM | P14618 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3557629 | 0.85 | ORAI1 (0.41) | MAPTSMN1; SMN2NPC1RAB9ALMNA | |
| SCHEMBL14379044 | 0.83 | ORAI1 (0.42) | MAPTSMN1; SMN2NPC1RAB9ALMNA | |
| SCHEMBL3559709 | 0.83 | ORAI1 (0.42) | MAPTSMN1; SMN2NPC1RAB9ALMNA | |
| SCHEMBL3556322 | 0.82 | ORAI1 (0.41) | MAPTSMN1; SMN2NPC1RAB9ALMNA | |
| SCHEMBL13438433 | 0.82 | ORAI1 (0.41) | MAPTSMN1; SMN2NPC1RAB9ALMNA | |
| SCHEMBL3559491 | 0.82 | ALDH1A1 (0.46) | MAPTSMN1; SMN2NPC1RAB9ALMNA | |
| SCHEMBL3567004 | 0.82 | ORAI1 (0.41) | MAPTSMN1; SMN2NPC1RAB9ALMNA | |
| SCHEMBL3556719 | 0.81 | ORAI1 (0.43) | MAPTSMN1; SMN2NPC1RAB9ALMNA | |
| SCHEMBL3560070 | 0.80 | ORAI1 (0.41) | MAPTSMN1; SMN2NPC1RAB9ALMNA | |
| SCHEMBL3557306 | 0.79 | ORAI1 (0.42) | MAPTSMN1; SMN2NPC1RAB9ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7705029-B2 | Acrylonitrile derivatives for inflammation and immune-related uses | SYNTA PHARMACEUTICALS CORP. (US) | 2010-04-27 | — | — | US | disclosed |
| US-20070270478-A1 | ACRYLONITRILE DERIVATIVES FOR INFLAMMATION AND IMMUNE-RELATED USES | SYNTA PHARMACEUTICALS CORP. (US) | 2007-11-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070270478-A1 | ACRYLONITRILE DERIVATIVES FOR INFLAMMATION AND IMMUNE-RELATED USES | IL1B, IL6, TLR4 | MAPT 643/4885SMN1; SMN2 3382/4885NPC1 601/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.